劍橋科技(603083.SH)完成註銷11.2385萬份股票期權
格隆匯1月3日丨劍橋科技(603083.SH)公佈,因激勵對象陳詠等5人離職已不符合激勵條件,同意對其對應的已獲授未行權的全部股票期權共計8.9570萬份予以註銷。因5名激勵對象個人評價結果未達標,同意對其對應的已獲授未行權的全部股票期權共計2.2815萬份予以註銷。合計待註銷的股票期權數量為11.2385萬份。
根據公司2018年第一次臨時股東大會授權,經中國證券登記結算有限責任公司上海分公司審核確認,上述11.2385萬份已授予未獲準行權股票期權註銷事宜已於2020年1月2日辦理完畢。
經調整後,激勵對象由原305人調整為300人,已授予未行權股票期權由490.7609萬份調整為479.5224萬份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.